The answer is pretty simple. The protocol was des
Post# of 148168
(Total Views: 520)
Posted On: 01/19/2021 1:30:26 PM
The answer is pretty simple. The protocol was designed when very little was known about COVID.
I dont believe the FDA would allow us to increase dosage, or change administration, as these things could affect the validity of the trial.
Once we show our data from this trial, they can begin to evaluate dosing procedures.
I dont believe the FDA would allow us to increase dosage, or change administration, as these things could affect the validity of the trial.
Once we show our data from this trial, they can begin to evaluate dosing procedures.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼